Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Antivirals market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Antivirals market. Detailed analysis of key players, along with key growth strategies adopted by Antivirals industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Cipla
Bristol-Myers-Squibb
Johnson & Johnson
Merck & Co
GSK
Gilead Sciences
AbbVie
F Hoffmann-La Roche AG
Mylan
Dr Reddy’s
Teva Pharmaceutical Industries
Aurobindo Pharma
By Type:
Generic
Branded
By End-User:
Application 1
HIV
Hepatitis
HSV
Influenza
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Antivirals Market
-
1.3 Market Segment by Type
-
1.3.1 China Antivirals Market Size and Growth Rate of Generic from 2016 to 2027
-
1.3.2 China Antivirals Market Size and Growth Rate of Branded from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Antivirals Market Size and Growth Rate of Application 1 from 2016 to 2027
-
1.4.2 China Antivirals Market Size and Growth Rate of HIV from 2016 to 2027
-
1.4.3 China Antivirals Market Size and Growth Rate of Hepatitis from 2016 to 2027
-
1.4.4 China Antivirals Market Size and Growth Rate of HSV from 2016 to 2027
-
1.4.5 China Antivirals Market Size and Growth Rate of Influenza from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Antivirals Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Antivirals Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Antivirals Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Antivirals Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Antivirals Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Antivirals Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Antivirals Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Antivirals Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Antivirals by Major Types
-
3.4.1 Market Size and Growth Rate of Generic
-
3.4.2 Market Size and Growth Rate of Branded
4 Segmentation of Antivirals Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Antivirals by Major End-Users
-
4.4.1 Market Size and Growth Rate of Antivirals in Application 1
-
4.4.2 Market Size and Growth Rate of Antivirals in HIV
-
4.4.3 Market Size and Growth Rate of Antivirals in Hepatitis
-
4.4.4 Market Size and Growth Rate of Antivirals in HSV
-
4.4.5 Market Size and Growth Rate of Antivirals in Influenza
5 Market Analysis by Regions
-
5.1 China Antivirals Production Analysis by Regions
-
5.2 China Antivirals Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Antivirals Landscape Analysis
-
6.1 North China Antivirals Landscape Analysis by Major Types
-
6.2 North China Antivirals Landscape Analysis by Major End-Users
7 Central China Antivirals Landscape Analysis
-
7.1 Central China Antivirals Landscape Analysis by Major Types
-
7.2 Central China Antivirals Landscape Analysis by Major End-Users
8 South China Antivirals Landscape Analysis
-
8.1 South China Antivirals Landscape Analysis by Major Types
-
8.2 South China Antivirals Landscape Analysis by Major End-Users
9 East China Antivirals Landscape Analysis
-
9.1 East China Antivirals Landscape Analysis by Major Types
-
9.2 East China Antivirals Landscape Analysis by Major End-Users
10 Northeast China Antivirals Landscape Analysis
-
10.1 Northeast China Antivirals Landscape Analysis by Major Types
-
10.2 Northeast China Antivirals Landscape Analysis by Major End-Users
11 Southwest China Antivirals Landscape Analysis
-
11.1 Southwest China Antivirals Landscape Analysis by Major Types
-
11.2 Southwest China Antivirals Landscape Analysis by Major End-Users
12 Northwest China Antivirals Landscape Analysis
-
12.1 Northwest China Antivirals Landscape Analysis by Major Types
-
12.2 Northwest China Antivirals Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Cipla
-
13.1.1 Cipla Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Bristol-Myers-Squibb
-
13.2.1 Bristol-Myers-Squibb Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Johnson & Johnson
-
13.3.1 Johnson & Johnson Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Merck & Co
-
13.4.1 Merck & Co Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 GSK
-
13.5.1 GSK Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Gilead Sciences
-
13.6.1 Gilead Sciences Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 AbbVie
-
13.7.1 AbbVie Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 F Hoffmann-La Roche AG
-
13.8.1 F Hoffmann-La Roche AG Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Mylan
-
13.9.1 Mylan Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Dr Reddy’s
-
13.10.1 Dr Reddy’s Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Teva Pharmaceutical Industries
-
13.11.1 Teva Pharmaceutical Industries Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Aurobindo Pharma
-
13.12.1 Aurobindo Pharma Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Antivirals Market Size and Growth Rate of Generic from 2016 to 2027
-
Figure China Antivirals Market Size and Growth Rate of Branded from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Antivirals Market Size and Growth Rate of Application 1 from 2016 to 2027
-
Figure China Antivirals Market Size and Growth Rate of HIV from 2016 to 2027
-
Figure China Antivirals Market Size and Growth Rate of Hepatitis from 2016 to 2027
-
Figure China Antivirals Market Size and Growth Rate of HSV from 2016 to 2027
-
Figure China Antivirals Market Size and Growth Rate of Influenza from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Antivirals Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Antivirals Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Antivirals Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Antivirals Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Antivirals Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Antivirals Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Antivirals Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Antivirals Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Antivirals
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Antivirals by Different Types from 2016 to 2027
-
Table Consumption Share of Antivirals by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Generic
-
Figure Market Size and Growth Rate of Branded
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Antivirals by Different End-Users from 2016 to 2027
-
Table Consumption Share of Antivirals by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Application 1
-
Figure Market Size and Growth Rate of HIV
-
Figure Market Size and Growth Rate of Hepatitis
-
Figure Market Size and Growth Rate of HSV
-
Figure Market Size and Growth Rate of Influenza
-
Table China Antivirals Production by Regions
-
Table China Antivirals Production Share by Regions
-
Figure China Antivirals Production Share by Regions in 2016
-
Figure China Antivirals Production Share by Regions in 2021
-
Figure China Antivirals Production Share by Regions in 2027
-
Table China Antivirals Consumption by Regions
-
Table China Antivirals Consumption Share by Regions
-
Figure China Antivirals Consumption Share by Regions in 2016
-
Figure China Antivirals Consumption Share by Regions in 2021
-
Figure China Antivirals Consumption Share by Regions in 2027
-
Table North China Antivirals Consumption by Types from 2016 to 2027
-
Table North China Antivirals Consumption Share by Types from 2016 to 2027
-
Figure North China Antivirals Consumption Share by Types in 2016
-
Figure North China Antivirals Consumption Share by Types in 2021
-
Figure North China Antivirals Consumption Share by Types in 2027
-
Table North China Antivirals Consumption by End-Users from 2016 to 2027
-
Table North China Antivirals Consumption Share by End-Users from 2016 to 2027
-
Figure North China Antivirals Consumption Share by End-Users in 2016
-
Figure North China Antivirals Consumption Share by End-Users in 2021
-
Figure North China Antivirals Consumption Share by End-Users in 2027
-
Table Central China Antivirals Consumption by Types from 2016 to 2027
-
Table Central China Antivirals Consumption Share by Types from 2016 to 2027
-
Figure Central China Antivirals Consumption Share by Types in 2016
-
Figure Central China Antivirals Consumption Share by Types in 2021
-
Figure Central China Antivirals Consumption Share by Types in 2027
-
Table Central China Antivirals Consumption by End-Users from 2016 to 2027
-
Table Central China Antivirals Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Antivirals Consumption Share by End-Users in 2016
-
Figure Central China Antivirals Consumption Share by End-Users in 2021
-
Figure Central China Antivirals Consumption Share by End-Users in 2027
-
Table South China Antivirals Consumption by Types from 2016 to 2027
-
Table South China Antivirals Consumption Share by Types from 2016 to 2027
-
Figure South China Antivirals Consumption Share by Types in 2016
-
Figure South China Antivirals Consumption Share by Types in 2021
-
Figure South China Antivirals Consumption Share by Types in 2027
-
Table South China Antivirals Consumption by End-Users from 2016 to 2027
-
Table South China Antivirals Consumption Share by End-Users from 2016 to 2027
-
Figure South China Antivirals Consumption Share by End-Users in 2016
-
Figure South China Antivirals Consumption Share by End-Users in 2021
-
Figure South China Antivirals Consumption Share by End-Users in 2027
-
Table East China Antivirals Consumption by Types from 2016 to 2027
-
Table East China Antivirals Consumption Share by Types from 2016 to 2027
-
Figure East China Antivirals Consumption Share by Types in 2016
-
Figure East China Antivirals Consumption Share by Types in 2021
-
Figure East China Antivirals Consumption Share by Types in 2027
-
Table East China Antivirals Consumption by End-Users from 2016 to 2027
-
Table East China Antivirals Consumption Share by End-Users from 2016 to 2027
-
Figure East China Antivirals Consumption Share by End-Users in 2016
-
Figure East China Antivirals Consumption Share by End-Users in 2021
-
Figure East China Antivirals Consumption Share by End-Users in 2027
-
Table Northeast China Antivirals Consumption by Types from 2016 to 2027
-
Table Northeast China Antivirals Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Antivirals Consumption Share by Types in 2016
-
Figure Northeast China Antivirals Consumption Share by Types in 2021
-
Figure Northeast China Antivirals Consumption Share by Types in 2027
-
Table Northeast China Antivirals Consumption by End-Users from 2016 to 2027
-
Table Northeast China Antivirals Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Antivirals Consumption Share by End-Users in 2016
-
Figure Northeast China Antivirals Consumption Share by End-Users in 2021
-
Figure Northeast China Antivirals Consumption Share by End-Users in 2027
-
Table Southwest China Antivirals Consumption by Types from 2016 to 2027
-
Table Southwest China Antivirals Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Antivirals Consumption Share by Types in 2016
-
Figure Southwest China Antivirals Consumption Share by Types in 2021
-
Figure Southwest China Antivirals Consumption Share by Types in 2027
-
Table Southwest China Antivirals Consumption by End-Users from 2016 to 2027
-
Table Southwest China Antivirals Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Antivirals Consumption Share by End-Users in 2016
-
Figure Southwest China Antivirals Consumption Share by End-Users in 2021
-
Figure Southwest China Antivirals Consumption Share by End-Users in 2027
-
Table Northwest China Antivirals Consumption by Types from 2016 to 2027
-
Table Northwest China Antivirals Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Antivirals Consumption Share by Types in 2016
-
Figure Northwest China Antivirals Consumption Share by Types in 2021
-
Figure Northwest China Antivirals Consumption Share by Types in 2027
-
Table Northwest China Antivirals Consumption by End-Users from 2016 to 2027
-
Table Northwest China Antivirals Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Antivirals Consumption Share by End-Users in 2016
-
Figure Northwest China Antivirals Consumption Share by End-Users in 2021
-
Figure Northwest China Antivirals Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Cipla
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla
-
Figure Sales and Growth Rate Analysis of Cipla
-
Figure Revenue and Market Share Analysis of Cipla
-
Table Product and Service Introduction of Cipla
-
Table Company Profile and Development Status of Bristol-Myers-Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers-Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers-Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers-Squibb
-
Table Product and Service Introduction of Bristol-Myers-Squibb
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Merck & Co
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co
-
Figure Sales and Growth Rate Analysis of Merck & Co
-
Figure Revenue and Market Share Analysis of Merck & Co
-
Table Product and Service Introduction of Merck & Co
-
Table Company Profile and Development Status of GSK
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK
-
Figure Sales and Growth Rate Analysis of GSK
-
Figure Revenue and Market Share Analysis of GSK
-
Table Product and Service Introduction of GSK
-
Table Company Profile and Development Status of Gilead Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences
-
Figure Sales and Growth Rate Analysis of Gilead Sciences
-
Figure Revenue and Market Share Analysis of Gilead Sciences
-
Table Product and Service Introduction of Gilead Sciences
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of F Hoffmann-La Roche AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche AG
-
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche AG
-
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche AG
-
Table Product and Service Introduction of F Hoffmann-La Roche AG
-
Table Company Profile and Development Status of Mylan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
-
Figure Sales and Growth Rate Analysis of Mylan
-
Figure Revenue and Market Share Analysis of Mylan
-
Table Product and Service Introduction of Mylan
-
Table Company Profile and Development Status of Dr Reddy’s
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy’s
-
Figure Sales and Growth Rate Analysis of Dr Reddy’s
-
Figure Revenue and Market Share Analysis of Dr Reddy’s
-
Table Product and Service Introduction of Dr Reddy’s
-
Table Company Profile and Development Status of Teva Pharmaceutical Industries
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries
-
Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries
-
Table Product and Service Introduction of Teva Pharmaceutical Industries
-
Table Company Profile and Development Status of Aurobindo Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurobindo Pharma
-
Figure Sales and Growth Rate Analysis of Aurobindo Pharma
-
Figure Revenue and Market Share Analysis of Aurobindo Pharma
-
Table Product and Service Introduction of Aurobindo Pharma
-
